Health care of Kyrgyzstan
Zdravoohraneniye Kyrgyzstana

ISSN 1694-8068 (Print)

ISSN 1694-805X (Online)

Log in

COVID-19 Pandemic and Lung Cancer (Literature Review)

https://dx.doi.org/10.51350/zdravkg2024.4.12.20.157.163
COVID-19 Pandemic and Lung Cancer (Literature Review)
Полный текст  

PDF (RUS)
Abstract About the authors References

Abstract

Introduction. Lung cancer is the leading cause of cancer-related mortality worldwide. According to WHO statistics, approximately 2.21 million new cases of lung cancer are diagnosed annually (14% of all cancers), leadingto 1.79 million deaths (15.7% of total cancer mortality). The COVID-19 pandemic caused by SARS-CoV-2 has significantly complicated the provision of care for patients with lung malignancies. Due to the disease itself and ongoing treatments, these patients often have compromised immunity, increasing their susceptibility to COVID-19 and the risk of severe complications. This review presents data from global scientific literature on the origin and evolution of human coronaviruses, including SARS-CoV-2 andits variants. It also discusses risk factors exacerbating disease severity, the impact of comorbidities, and the influence of SARS-CoV-2 evolution on COVID-19 diagnostics. Therefore, the medical community must be prepared for future variants and outbreaks of coronavirus infections. Objective. To investigate the impact of human coronaviruses, particularly SARS-CoV-2 and its variants, on the diagnosis, clinical progression, and prognosis of lungmalignancies. Materials and Methods. Data from global scientific literature on the origin and evolution of human coronaviruses, including SARS-CoV-2 and its variants, were extensively analyzed. Discussion. Based on the analysis of scientific literature and conducted studies, the COVID-19 pandemic has profoundly affected the diagnosis and treatment of cancer patients, particularly those with lung cancer. Key challenges include the differentiation between coronavirus pneumonia and lung cancer, as well as the high risk of severe disease progression in immunocompromised patients. Additional restrictive measures, such as transitioning to telemedicine, postponement of surgeries, and screening procedures, have further exacerbated the situation. Conclusion. According to international studies and research, the COVID-19 pandemic has had a negative impact on the treatment and prognosis of lung cancer patients. The medical community must take lessons from this experience to respond effectively to future pandemics. Special attention should be given to developing strategies for diagnosing and treating cancer patients during outbreaks of new infections.

About the authors

Бейшембаев Мукаш Итикулович, доктор медицинских наук, профессор, Ведущий научный сотрудник Национального центра онкологии и гематологии, отделения торакальной онкологии №5, Бишкек, Кыргызская Республика
Азизова Мээрим Азизовна, врач онколог Национального центра онкологии и гематологии, отделения торакальной онкологии №5, Бишкек, Кыргызская Республика
Балпаев Уран Доктурбекович, врач онколог Национального центра онкологии и гематологии, отделения торакальной онкологии №5, Бишкек, Кыргызская Республика
Курбанова Камилла Абдымажитовна, врач онколог Национального центра онкологии и гематологии, отделения торакальной онкологии №5, Бишкек, Кыргызская Республика

Beyshembaev Mukash Itikulovich, Doctor of Medical Sciences, Professor, Leading Researcher, National Center for Oncology and Hematology, Department of Thoracic Oncology  No. 5, Bishkek, Kyrgyz Republic

Azizova Meerim Azizovna, oncologist, National Center of Oncology and Hematology, Department of Thoracic Oncology No. 5, Bishkek, Kyrgyz Republic
Balpaev Uran Dokturbekovich, oncologist, National Center of Oncology and Hematology, Department of Thoracic Oncology No. 5, Bishkek, Kyrgyz Republic

Kurbanova Kamilla Abdymazhitovna, oncologist, National Center of Oncology and Hematology, Department of Thoracic Oncology No. 5, Bishkek, Kyrgyz Republic

 

Бейшембаев Мукаш Итикулович, медицина илимдеринин доктору, профессор, Улуттук онкология жана гематология борборунун жетектөөчү илимий кызматкери, №5 көкүрөк онкологиясы кафедрасы, Бишкек, Кыргыз Республикасы
Азизова Мээрим Азизовна, Улуттук онкология жана гематология борборунун №5 көкүрөк онкология бөлүмүнүн онкологу, Бишкек, Кыргыз Республикасы
Балпаев Уран Доктурбекович, Улуттук онкология жана гематология борборунун №5 көкүрөк онкология бөлүмүнүн онкологу, Бишкек, Кыргыз Республикасы
Курбанова Камилла Абдымажитовна, Улуттук онкология жана гематология борборунун №5 көкүрөк онкология бөлүмүнүн онкологу, Бишкек, Кыргыз Республикасы

References

1. Ассоциация онкологов России. Итоги круглого стола в области лечения рака легкого. – 2021. – URL: https://oncology-as
sociation.ru/itogi-kruglogo-stola-v-oblasti-lecheniya-raka-legkogo
2. Zhu, N., Zhang, D., Wang, W., et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 2020,
382(8): 727–733. DOI: 10.1056/NEJMoa2001017.
3. Worldometer. COVID-19 Coronavirus Pandemic. 2023. URL: https://www.worldometers.info/coronavirus/ (дата обращения:
25.03.2023).
4. Hu, B., Guo, H., Zhou, P., Shi, Z.-L. Characteristics of SARS-CoV-2 and COVID-19. NatRev Microbiol, 2021, 19(3): 141–154.
DOI: 10.1038/s41579-020-00459-7.
5. Liang, W., Guan, W., Chen, R., Wang, W., et al. Cancer patients in SARS-CoV-2 infection:a nationwide analysis in China. Lancet
Oncol, 2020, 21(3): 335–337. DOI:10.1016/S1470-2045(20)30096-6.
6. Liu, S.T.H., Lin, H.-M., Baine, I., et al. Convalescent Plasma Treatment of Severe COVID-19. Nat Med, 2020, 26: 1708–1713.
DOI: 10.1038/s41591-020-1088-9.
7. Low, Z.Y., Yip, A.J.W., Lal, S.K. Repositioning Ivermectin for COVID-19 Treatment: Molecular Mechanisms of Action against
SARS-CoV-2 Replication. Biochim Biophys Acta Mol Basis Dis, 2022, 1868: 166294. DOI: 10.1016/j.bbadis.2020.166294.
8. Jo, W.K., Drosten, C., Drexler, J.F. The Evolutionary Dynamics of Endemic Human Coronaviruses. Virus Evol, 2021, 7: veab020.
DOI: 10.1093/ve/veab020.
9. Xu, Y., Liu, H., Hu, K., Wang, M. Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coro
navirus Disease (COVID-19). Zhongguo Fei Ai Za Zhi, 2020, 23(3): 136–141. DOI: 10.3779/j.issn.1009-3419.2020.
10. Huynh, J., Li, S., Yount, B., et al. Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63. J Virol, 2012, 86:
12816–12825. DOI: 10.1128/JVI.00906-12.
11. Woo, P.C.Y., Lau, S.K.P., Chu, C., et al. Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus
HKU1. J Virol, 2005, 79: 884–895. DOI: 10.1128/JVI.79.2.884-895.2005.
12. Fung, T.S., Liu, D.X. Human Coronavirus: Host-Pathogen Interaction. Annu Rev Microbiol, 2019, 73: 529–557. DOI: 10.1146/annurev-micro-020518-115759.

13. Abdul-Rasool, S., Fielding, B.C. Understanding Human Coronavirus HCoV-NL63.Open Virol J, 2010, 4: 76–84. DOI:
10.2174/1874357901004020076.
14. Liu, D.X., Liang, J.Q., Fung, T.S. Human Coronavirus-229E, -OC43, -NL63 and -HKU1(Coronaviridae). In Encyclopedia of Vi
rology; Elsevier: Amsterdam, The Netherlands,2021; pp. 428–440. DOI: 10.1016/B978-0-12-814515-9.00078-8.
15. Yip, A.J.W., Low, Z.Y., Chow, V.T.K., Lal, S.K. Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity.Viruses, 2022, 14: 1345. DOI: 10.3390/v14071345.
16. Van der Hoek, L., Pyrc, K., Jebbink, M.F., et al. Identification of a New Human Coronavirus. Nat Med, 2004, 10: 368–373. DOI:
10.1038/nm1024.
17. Sun, W., Liao, J.-P., Yu, K.-Y., et al. A Severe Case of Human Coronavirus 229E Pneumonia in an Elderly Man with Diabetes
Mellitus: A Case Report. BMC Infect Dis, 2021, 21: 524. DOI: 10.1186/s12879-021-06270-1.
18. Lau, S.K.P., Woo, P.C.Y., Li, K.S.M., et al. Discovery of a Novel Coronavirus, China Rattus Coronavirus HKU24, from Norway
Rats. J Virol, 2015, 89: 3076–3092. DOI:10.1128/JVI.03478-14.
19. Zeng, Z.-Q., Chen, D.-H., Tan, W.-P., et al. Epidemiology and Clinical Characteristics of Human Coronaviruses. Eur J Clin Mi
crobiol Infect Dis, 2018, 37: 363–369. DOI: 10.1007/s10096-018-3181-1.
20. Kutter, J.S., Spronken, M.I., Fraaij, P.L., et al. Transmission Routes of Respiratory Viruses among Humans. Curr Opin Virol,
2018, 28: 142–151. DOI:10.1016/j.coiro.2018.01.006.
21. Yan, Y.; Chang, L.; Wang, L. Laboratory Testing of SARS-CoV, MERS-CoV and SARS-CoV-2 (2019-nCoV): Current Status,
Challenges and Countermeasures. Rev Med Virol, 2020, 30: e2106. DOI: 10.1002/rmv.2106.
22. CDC. Human Coronavirus Types. Centers for Disease Control and Prevention. URL: https://www.cdc.gov/coronavirus/types.html(дата обращения: 13.03.2023).
23. Su, S., Wong, G., Shi, W., Liu, J., Lai, A.C.K., Zhou, J., Liu, W., Bi, Y., Gao, G.F. Epidemiology, Genetic Recombination and
Pathogenesis of Coronaviruses. Trends Microbiol, 2016, 24: 490–502. DOI: 10.1016/j.tim.2016.03.003.
24. Vassilara, F., Spyridaki, A., Pothitos, G., Deliveliotou, A., Papadopoulos, A. A Rare Case of Human Coronavirus 229E Associated with Acute Respiratory Distress Syndrome in a Healthy Adult. Case Rep Infect Dis, 2018: 6796839. DOI: 10.1155/2018/6796839.
25. Sun, W., Liao, J.-P., Yu, K.-Y., Qiu, J.-X., Que, C.-L., Wang, G.-F., Ma, J. A Severe Case of Human Coronavirus 229E Pneumonia in an Elderly Man with Diabetes Mellitus: A Case Report. BMC Infect Dis, 2021, 21: 524. DOI: 10.1186/s12879-021-06270-1.
26. Van der Hoek, L., Pyrc, K., Jebbink, M.F., Vermeulen-Oost, W., Berkhout, R.J.M., et al. Identification of a New Human Coronavirus. Nat Med, 2004, 10: 368–373. DOI: 10.1038/nm1024.
27. Huynh, J., Li, S., Yount, B., Smith, A., Sturges, L., Olsen, J.C., et al. Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63. J Virol, 2012, 86: 12816–12825. DOI: 10.1128/JVI.00906-12.
28. Woo, P.C.Y., Lau, S.K.P., Chu, C., Chan, K., Tsoi, H., Huang, Y., Wong, B.H.L., et al. Characterization and Complete Genome Se
quence of a Novel Coronavirus, Coronavirus HKU1. J Virol, 2005, 79: 884–895. DOI: 10.1128/JVI.79.2.884-895.2005.
29. Fung, T.S., Liu, D.X. Human Coronavirus: Host-Pathogen Interaction. Annu Rev Microbiol, 2019, 73: 529–557. DOI: 10.1146/annurev-micro-020518-115759.
30. Abdul-Rasool, S., Fielding, B.C. Understanding Human Coronavirus HCoV-NL63. Open Virol J, 2010, 4: 76–84. DOI:
10.2174/1874357901004020076.
31. Kutter, J.S., Spronken, M.I., Fraaij, P.L., Fouchier, R.A., Herfst, S. Transmission Routes of Respiratory Viruses among Humans.
Curr Opin Virol, 2018, 28: 142–151. DOI: 10.1016/j.coviro.2018.01.006.
32. Liu, D.X., Liang, J.Q., Fung, T.S. Human Coronavirus-229E, -OC43, -NL63 and -HKU1 (Coronaviridae). In Encyclopedia of Vi
rology; Elsevier: Amsterdam, The Netherlands, 2021; pp. 428–440. DOI: 10.1016/B978-0-12-814515-9.00078-8.
33. Yip, A.J.W., Low, Z.Y., Chow, V.T.K., Lal, S.K. Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity.Viruses, 2022, 14: 1345. DOI: 10.3390/v14071345.

1. Association of Oncologists of Russia. Results of the round table on lung cancer treatment. – 2021. – URL: https://oncology-as<br< a=""> />sociation.ru/itogi-kruglogo-stola-v-oblasti-lecheniya-raka-legkogo
2. Zhu, N., Zhang, D., Wang, W., et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 2020,
382(8): 727–733. DOI: 10.1056/NEJMoa2001017.
3. Worldometer. COVID-19 Coronavirus Pandemic. 2023. URL: </br<>https://www.worldometers.info/coronavirus/ (date of access:
25.03.2023).
4. Hu, B., Guo, H., Zhou, P., Shi, Z.-L. Characteristics of SARS-CoV-2 and COVID-19. NatRev Microbiol, 2021, 19(3): 141–154.
DOI: 10.1038/s41579-020-00459-7.
5. Liang, W., Guan, W., Chen, R., Wang, W., et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet
Oncol, 2020, 21(3): 335–337. DOI:10.1016/S1470-2045(20)30096-6.
6. Liu, S. T. H., Lin, H.-M., Baine, I., et al. Convalescent Plasma Treatment of Severe COVID-19. Nat Med 2020, 26:1708–1713.
DOI: 10.1038/s41591-020-1088-9.
7. Low, Z.Y., Yip, A.J.W., Lal, S.K. Repositioning Ivermectin for COVID-19 Treatment: Molecular Mechanisms of Action against
SARS-CoV-2 Replication. Biochim Biophys Acta Mol Basis Dis, 2022, 1868: 166294. DOI: 10.1016/j.bbadis.2020.166294.
8. Jo, W.K., Drosten, C., Drexler, J.F. The Evolutionary Dynamics of Endemic Human Coronaviruses. Virus Evol, 2021, 7: veab020.
DOI: 10.1093/ve/veab020.
9. Xu, Y., Liu, H., Hu, K., Wang, M. Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coro
navirus Disease (COVID-19). Zhongguo Fei Ai Za Zhi, 2020, 23(3): 136–141. DOI: 10.3779/j.issn.1009-3419.2020.
10. Huynh, J., Li, S., Yount, B., et al. Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63. J Virol, 2012, 86:
12816–12825. DOI: 10.1128/JVI.00906-12.
11. Woo, P. C. Y., Lau, S. K. P., Chu, C., et al. Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1. J Virol 2005, 79:884–895. DOI: 10.1128/JVI.79.2.884-895.2005.
12. Fung, T.S., Liu, D.X. Human Coronavirus: Host-Pathogen Interaction. Annu Rev Microbiol, 2019, 73:529–557. DOI: 10.1146/annurev-micro-020518-115759.

13. Abdul-Rasool, S., Fielding, B.C. Understanding Human Coronavirus HCoV-NL63.Open Virol J, 2010, 4: 76–84. DOI:
10.2174/1874357901004020076.
14. Liu, D.X., Liang, J.Q., Fung, T.S. Human Coronavirus-229E, -OC43, -NL63 and -HKU1(Coronaviridae). In Encyclopedia of Vi
rology; Elsevier: Amsterdam, The Netherlands,2021; pp. 428–440. DOI: 10.1016/B978-0-12-814515-9.00078-8.
15. Yip, A.J.W., Low, Z.Y., Chow, V.T.K., Lal, S.K. Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity.Viruses, 2022, 14: 1345. DOI: 10.3390/v14071345.
16. Van der Hoek, L., Pyrc, K., Jebbink, M.F., et al. Identification of a New Human Coronavirus. Nat Med, 2004, 10: 368–373. DOI:
10.1038/nm1024.
17. Sun, W., Liao, J.-P., Yu, K.-Y., et al. A Severe Case of Human Coronavirus 229E Pneumonia in an Elderly Man with Diabetes
Mellitus: A Case Report. BMC Infect Dis, 2021, 21: 524. DOI: 10.1186/s12879-021-06270-1.
18. Lau, S.K.P., Woo, P.C.Y., Li, K.S.M., et al. Discovery of a Novel Coronavirus, China Rattus Coronavirus HKU24, from Norway
Rats. J Virol, 2015, 89: 3076–3092. DOI:10.1128/JVI.03478-14.
19. Zeng, Z.-Q., Chen, D.-H., Tan, W.-P., et al. Epidemiology and Clinical Characteristics of Human Coronaviruses. Eur J Clin Mi
crobiol Infect Dis, 2018, 37: 363–369. DOI: 10.1007/s10096-018-3181-1.
20. Kutter, J.S., Spronken, M.I., Fraaij, P.L., et al. Transmission Routes of Respiratory Viruses among Humans. Curr Opin Virol,
2018, 28: 142–151. DOI:10.1016/j.coiro.2018.01.006.
21. Yan, Y.; Chang, L.; Wang, L. Laboratory Testing of SARS-CoV, MERS-CoV and SARS-CoV-2 (2019-nCoV): Current Status,
Challenges and Countermeasures. Rev Med Virol, 2020, 30: e2106. DOI: 10.1002/rmv.2106.
22. CDC. Human Coronavirus Types. Centers for Disease Control and Prevention. URL: https://www.cdc.gov/coronavirus/types.html(дата обращения: 13.03.2023).
23. Su, S., Wong, G., Shi, W., Liu, J., Lai, A.C.K., Zhou, J., Liu, W., Bi, Y., Gao, G.F. Epidemiology, Genetic Recombination and
Pathogenesis of Coronaviruses. Trends Microbiol, 2016, 24: 490–502. DOI: 10.1016/j.tim.2016.03.003.
24. Vassilara, F., Spyridaki, A., Pothitos, G., Deliveliotou, A., Papadopoulos, A. A Rare Case of Human Coronavirus 229E Associated with Acute Respiratory Distress Syndrome in a Healthy Adult. Case Rep Infect Dis, 2018: 6796839. DOI: 10.1155/2018/6796839.
25. Sun, W., Liao, J.-P., Yu, K.-Y., Qiu, J.-X., Que, C.-L., Wang, G.-F., Ma, J. A Severe Case of Human Coronavirus 229E Pneumonia in an Elderly Man with Diabetes Mellitus: A Case Report. BMC Infect Dis, 2021, 21: 524. DOI: 10.1186/s12879-021-06270-1.
26. Van der Hoek, L., Pyrc, K., Jebbink, M.F., Vermeulen-Oost, W., Berkhout, R.J.M., et al. Identification of a New Human Coronavirus. Nat Med, 2004, 10: 368–373. DOI: 10.1038/nm1024.
27. Huynh, J., Li, S., Yount, B., Smith, A., Sturges, L., Olsen, J.C., et al. Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63. J Virol, 2012, 86: 12816–12825. DOI: 10.1128/JVI.00906-12.
28. Woo, P.C.Y., Lau, S.K.P., Chu, C., Chan, K., Tsoi, H., Huang, Y., Wong, B.H.L., et al. Characterization and Complete Genome Se
quence of a Novel Coronavirus, Coronavirus HKU1. J Virol, 2005, 79: 884–895. DOI: 10.1128/JVI.79.2.884-895.2005.
29. Fung, T.S., Liu, D.X. Human Coronavirus: Host-Pathogen Interaction. Annu Rev Microbiol, 2019, 73: 529–557. DOI: 10.1146/annurev-micro-020518-115759.
30. Abdul-Rasool, S., Fielding, B.C. Understanding Human Coronavirus HCoV-NL63. Open Virol J, 2010, 4: 76–84. DOI:
10.2174/1874357901004020076.
31. Kutter, J.S., Spronken, M.I., Fraaij, P.L., Fouchier, R.A., Herfst, S. Transmission Routes of Respiratory Viruses among Humans.
Curr Opin Virol, 2018, 28: 142–151. DOI: 10.1016/j.coviro.2018.01.006.
32. Liu, D.X., Liang, J.Q., Fung, T.S. Human Coronavirus-229E, -OC43, -NL63 and -HKU1 (Coronaviridae). In Encyclopedia of Vi
rology; Elsevier: Amsterdam, The Netherlands, 2021; pp. 428–440. DOI: 10.1016/B978-0-12-814515-9.00078-8.
33. Yip, A.J.W., Low, Z.Y., Chow, V.T.K., Lal, S.K. Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity.Viruses, 2022, 14: 1345. DOI: 10.3390/v14071345.

1. Россиянын онкологдорунун ассоциациясы. Өпкө рагын дарылоо жаатындагы тегерек столдун жыйынтыгы. – 2021. – URL: https://oncology-as<br< a=""> />sociation.ru/itogi-kruglogo-stola-v-oblasti-lecheniya-raka-legkogo
2. Чжу, Н., Чжан, Д., Ванг, В., ж.б. Кытайдагы пневмония менен ооруган жаңы коронавирус, 2019. N Engl J Med, 2020,
382(8): 727–733. DOI: 10.1056/NEJMoa2001017.
3. Worldometer. COVID-19 Коронавирустук пандемия. 2023. URL: </br<>https://www.worldometers.info/coronavirus/ (кирүү күнү:25.03.2023).
4. Ху, Б., Го, Х., Чжоу, П., Ши, З.-Л. SARS-CoV-2 жана COVID-19 мүнөздөмөлөрү. NatRev Microbiol, 2021, 19(3): 141–154.
DOI: 10.1038/s41579-020-00459-7.
5. Liang, W., Guan, W., Chen, R., Wang, W., et al. SARS-CoV-2 инфекциясындагы онкологиялык оорулуулар: Кытайдагы жалпы улуттук анализ. Лансет Онкол, 2020, 21(3): 335–337. DOI:10.1016/S1470-2045(20)30096-6.
6. Liu, S.T.H., Lin, H.-M., Baine, I., et al. Оор COVID-19 үчүн конвалесценттик плазма менен дарылоо. Нат Мед, 2020, 26: 1708–1713. DOI: 10.1038/s41591-020-1088-9.
7. Low, Z.Y., Yip, A.J.W., Lal, S.K. Ивермектинди COVID-19 дарылоо үчүн кайра жайгаштыруу: каршы аракеттенүүнүн молекулярдык механизмдери SARS-CoV-2 репликациясы. Biochim Biophys Acta Mol Basis Dis, 2022, 1868: 166294. DOI: 10.1016/j.bbadis.2020.166294.
8. Джо, В.К., Дростен, Ч., Дрекслер, Дж.Ф. Адамдын эндемикалык коронавирустарынын эволюциялык динамикасы. Virus Evol, 2021, 7: veab020. DOI: 10.1093/ve/veab020.
9. Xu, Y., Liu, H., Hu, K., Wang, M. 2019 Роман Коро башталганда өпкө рагы менен ооруган бейтаптарды клиникалык башкаруунавирус оорусу (COVID-19). Чжунго Фэй Ай За Чжи, 2020, 23(3): 136–141. DOI: 10.3779/j.issn.1009-3419.2020.
10. Huynh, J., Li, S., Yount, B., et al. Адамдын NL63 коронавирусунун штаммынын зооноздук келип чыгышын колдогон далилдер. Дж Вирол, 2012, 86:12816–12825. DOI: 10.1128/JVI.00906-12.
11. Woo, P.C.Y., Lau, S.K.P., Chu, C., et al. Жаңы коронавирустун, Коронавирустун мүнөздөмөсү жана толук геномунун ырааттуулугу HKU1. Дж Вирол, 2005, 79: 884–895. DOI: 10.1128/JVI.79.2.884-895.2005.
12. Фунг, Т.С., Лю, Д.Х. Адамдын коронавирусу: Хост-патогендин өз ара аракеттенүүсү. Annu Rev Microbiol, 2019, 73: 529–557. DOI: 10.1146/annurev-micro-020518-115759.

13. Abdul-Rasool, S., Fielding, B.C. Understanding Human Coronavirus HCoV-NL63.Open Virol J, 2010, 4: 76–84. DOI:
10.2174/1874357901004020076.
14. Liu, D.X., Liang, J.Q., Fung, T.S. Human Coronavirus-229E, -OC43, -NL63 and -HKU1(Coronaviridae). In Encyclopedia of Vi
rology; Elsevier: Amsterdam, The Netherlands,2021; pp. 428–440. DOI: 10.1016/B978-0-12-814515-9.00078-8.
15. Yip, A.J.W., Low, Z.Y., Chow, V.T.K., Lal, S.K. Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity.Viruses, 2022, 14: 1345. DOI: 10.3390/v14071345.
16. Van der Hoek, L., Pyrc, K., Jebbink, M.F., et al. Identification of a New Human Coronavirus. Nat Med, 2004, 10: 368–373. DOI:
10.1038/nm1024.
17. Sun, W., Liao, J.-P., Yu, K.-Y., et al. A Severe Case of Human Coronavirus 229E Pneumonia in an Elderly Man with Diabetes
Mellitus: A Case Report. BMC Infect Dis, 2021, 21: 524. DOI: 10.1186/s12879-021-06270-1.
18. Lau, S.K.P., Woo, P.C.Y., Li, K.S.M., et al. Discovery of a Novel Coronavirus, China Rattus Coronavirus HKU24, from Norway
Rats. J Virol, 2015, 89: 3076–3092. DOI:10.1128/JVI.03478-14.
19. Zeng, Z.-Q., Chen, D.-H., Tan, W.-P., et al. Epidemiology and Clinical Characteristics of Human Coronaviruses. Eur J Clin Mi
crobiol Infect Dis, 2018, 37: 363–369. DOI: 10.1007/s10096-018-3181-1.
20. Kutter, J.S., Spronken, M.I., Fraaij, P.L., et al. Transmission Routes of Respiratory Viruses among Humans. Curr Opin Virol,
2018, 28: 142–151. DOI:10.1016/j.coiro.2018.01.006.
21. Yan, Y.; Chang, L.; Wang, L. Laboratory Testing of SARS-CoV, MERS-CoV and SARS-CoV-2 (2019-nCoV): Current Status,
Challenges and Countermeasures. Rev Med Virol, 2020, 30: e2106. DOI: 10.1002/rmv.2106.
22. CDC. Human Coronavirus Types. Centers for Disease Control and Prevention. URL: https://www.cdc.gov/coronavirus/types.html(дата обращения: 13.03.2023).
23. Su, S., Wong, G., Shi, W., Liu, J., Lai, A.C.K., Zhou, J., Liu, W., Bi, Y., Gao, G.F. Epidemiology, Genetic Recombination and
Pathogenesis of Coronaviruses. Trends Microbiol, 2016, 24: 490–502. DOI: 10.1016/j.tim.2016.03.003.
24. Vassilara, F., Spyridaki, A., Pothitos, G., Deliveliotou, A., Papadopoulos, A. A Rare Case of Human Coronavirus 229E Associated with Acute Respiratory Distress Syndrome in a Healthy Adult. Case Rep Infect Dis, 2018: 6796839. DOI: 10.1155/2018/6796839.
25. Sun, W., Liao, J.-P., Yu, K.-Y., Qiu, J.-X., Que, C.-L., Wang, G.-F., Ma, J. A Severe Case of Human Coronavirus 229E Pneumonia in an Elderly Man with Diabetes Mellitus: A Case Report. BMC Infect Dis, 2021, 21: 524. DOI: 10.1186/s12879-021-06270-1.
26. Van der Hoek, L., Pyrc, K., Jebbink, M.F., Vermeulen-Oost, W., Berkhout, R.J.M., et al. Identification of a New Human Coronavirus. Nat Med, 2004, 10: 368–373. DOI: 10.1038/nm1024.
27. Huynh, J., Li, S., Yount, B., Smith, A., Sturges, L., Olsen, J.C., et al. Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63. J Virol, 2012, 86: 12816–12825. DOI: 10.1128/JVI.00906-12.
28. Woo, P.C.Y., Lau, S.K.P., Chu, C., Chan, K., Tsoi, H., Huang, Y., Wong, B.H.L., et al. Characterization and Complete Genome Se
quence of a Novel Coronavirus, Coronavirus HKU1. J Virol, 2005, 79: 884–895. DOI: 10.1128/JVI.79.2.884-895.2005.
29. Fung, T.S., Liu, D.X. Human Coronavirus: Host-Pathogen Interaction. Annu Rev Microbiol, 2019, 73: 529–557. DOI: 10.1146/annurev-micro-020518-115759.
30. Abdul-Rasool, S., Fielding, B.C. Understanding Human Coronavirus HCoV-NL63. Open Virol J, 2010, 4: 76–84. DOI:
10.2174/1874357901004020076.
31. Kutter, J.S., Spronken, M.I., Fraaij, P.L., Fouchier, R.A., Herfst, S. Transmission Routes of Respiratory Viruses among Humans.
Curr Opin Virol, 2018, 28: 142–151. DOI: 10.1016/j.coviro.2018.01.006.
32. Liu, D.X., Liang, J.Q., Fung, T.S. Human Coronavirus-229E, -OC43, -NL63 and -HKU1 (Coronaviridae). In Encyclopedia of Vi
rology; Elsevier: Amsterdam, The Netherlands, 2021; pp. 428–440. DOI: 10.1016/B978-0-12-814515-9.00078-8.
33. Yip, A.J.W., Low, Z.Y., Chow, V.T.K., Lal, S.K. Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity.Viruses, 2022, 14: 1345. DOI: 10.3390/v14071345.

Keywords
SARS-CoV-2 , Pandemic , Coronavirus , Oncology , COVID-19 , Lung cancer
Для цитирования

Бейшембаев М.И., Азизова М.А., Балпаев У.Д., Курбанова К.А. Пандемия коронавируса COVID-19 и рак легкого (обзор литературы). Научно-практический журнал «Здравоохранение Кыргызстана» 2024, № 4, с.157-163.  https://dx.doi.org/10.51350/zdravkg2024.4.12.20.157.163
For citation

Beyshembayev M.I., Azizova M.A., Balpaev U.D., Kurbanova K.A.COVID-19 Pandemic and Lung Cancer (Literature
Review).Scientific and practical journal “Health care of Kyrgyzstan” 2024, No.4, p.157-163. https://dx.doi.org/10.51350/zdravkg2024.4.12.20.157.163
Цитата үчүн

Бейшембаев М.И., Азизова М.А., Балпаев У.Д., Курбанова К.А. COVID-19 Пандемиясы жана опкөнун залалдуу шишиктери (Адабиятка Сын көз караш). "Кыргызстандын саламаттык сактоо" илимий-практикалык журналы
2024, № 4, б. 157-163.  https://dx.doi.org/10.51350/zdravkg2024.4.12.20.157.163
Authors Beishembaev M.I. , Azizova M.A., Balpaev U.D., Kurbanova K.A.
Link doi.org https://dx.doi.org/10.51350/zdravkg2024.4.12.20.157.163
Pages 157-163
Keywords SARS-CoV-2, Pandemic, Coronavirus, Oncology, COVID-19, Lung cancer
Russian
Об авторах

Бейшембаев Мукаш Итикулович, доктор медицинских наук, профессор, Ведущий научный сотрудник Национального центра онкологии и гематологии, отделения торакальной онкологии №5, Бишкек, Кыргызская Республика
Азизова Мээрим Азизовна, врач онколог Национального центра онкологии и гематологии, отделения торакальной онкологии №5, Бишкек, Кыргызская Республика
Балпаев Уран Доктурбекович, врач онколог Национального центра онкологии и гематологии, отделения торакальной онкологии №5, Бишкек, Кыргызская Республика
Курбанова Камилла Абдымажитовна, врач онколог Национального центра онкологии и гематологии, отделения торакальной онкологии №5, Бишкек, Кыргызская Республика
Полный текст

PDF (RUS)
Список литературы

1. Ассоциация онкологов России. Итоги круглого стола в области лечения рака легкого. – 2021. – URL: https://oncology-as
sociation.ru/itogi-kruglogo-stola-v-oblasti-lecheniya-raka-legkogo
2. Zhu, N., Zhang, D., Wang, W., et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 2020,
382(8): 727–733. DOI: 10.1056/NEJMoa2001017.
3. Worldometer. COVID-19 Coronavirus Pandemic. 2023. URL: https://www.worldometers.info/coronavirus/ (дата обращения:
25.03.2023).
4. Hu, B., Guo, H., Zhou, P., Shi, Z.-L. Characteristics of SARS-CoV-2 and COVID-19. NatRev Microbiol, 2021, 19(3): 141–154.
DOI: 10.1038/s41579-020-00459-7.
5. Liang, W., Guan, W., Chen, R., Wang, W., et al. Cancer patients in SARS-CoV-2 infection:a nationwide analysis in China. Lancet
Oncol, 2020, 21(3): 335–337. DOI:10.1016/S1470-2045(20)30096-6.
6. Liu, S.T.H., Lin, H.-M., Baine, I., et al. Convalescent Plasma Treatment of Severe COVID-19. Nat Med, 2020, 26: 1708–1713.
DOI: 10.1038/s41591-020-1088-9.
7. Low, Z.Y., Yip, A.J.W., Lal, S.K. Repositioning Ivermectin for COVID-19 Treatment: Molecular Mechanisms of Action against
SARS-CoV-2 Replication. Biochim Biophys Acta Mol Basis Dis, 2022, 1868: 166294. DOI: 10.1016/j.bbadis.2020.166294.
8. Jo, W.K., Drosten, C., Drexler, J.F. The Evolutionary Dynamics of Endemic Human Coronaviruses. Virus Evol, 2021, 7: veab020.
DOI: 10.1093/ve/veab020.
9. Xu, Y., Liu, H., Hu, K., Wang, M. Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coro
navirus Disease (COVID-19). Zhongguo Fei Ai Za Zhi, 2020, 23(3): 136–141. DOI: 10.3779/j.issn.1009-3419.2020.
10. Huynh, J., Li, S., Yount, B., et al. Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63. J Virol, 2012, 86:
12816–12825. DOI: 10.1128/JVI.00906-12.
11. Woo, P.C.Y., Lau, S.K.P., Chu, C., et al. Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus
HKU1. J Virol, 2005, 79: 884–895. DOI: 10.1128/JVI.79.2.884-895.2005.
12. Fung, T.S., Liu, D.X. Human Coronavirus: Host-Pathogen Interaction. Annu Rev Microbiol, 2019, 73: 529–557. DOI: 10.1146/annurev-micro-020518-115759.

13. Abdul-Rasool, S., Fielding, B.C. Understanding Human Coronavirus HCoV-NL63.Open Virol J, 2010, 4: 76–84. DOI:
10.2174/1874357901004020076.
14. Liu, D.X., Liang, J.Q., Fung, T.S. Human Coronavirus-229E, -OC43, -NL63 and -HKU1(Coronaviridae). In Encyclopedia of Vi
rology; Elsevier: Amsterdam, The Netherlands,2021; pp. 428–440. DOI: 10.1016/B978-0-12-814515-9.00078-8.
15. Yip, A.J.W., Low, Z.Y., Chow, V.T.K., Lal, S.K. Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity.Viruses, 2022, 14: 1345. DOI: 10.3390/v14071345.
16. Van der Hoek, L., Pyrc, K., Jebbink, M.F., et al. Identification of a New Human Coronavirus. Nat Med, 2004, 10: 368–373. DOI:
10.1038/nm1024.
17. Sun, W., Liao, J.-P., Yu, K.-Y., et al. A Severe Case of Human Coronavirus 229E Pneumonia in an Elderly Man with Diabetes
Mellitus: A Case Report. BMC Infect Dis, 2021, 21: 524. DOI: 10.1186/s12879-021-06270-1.
18. Lau, S.K.P., Woo, P.C.Y., Li, K.S.M., et al. Discovery of a Novel Coronavirus, China Rattus Coronavirus HKU24, from Norway
Rats. J Virol, 2015, 89: 3076–3092. DOI:10.1128/JVI.03478-14.
19. Zeng, Z.-Q., Chen, D.-H., Tan, W.-P., et al. Epidemiology and Clinical Characteristics of Human Coronaviruses. Eur J Clin Mi
crobiol Infect Dis, 2018, 37: 363–369. DOI: 10.1007/s10096-018-3181-1.
20. Kutter, J.S., Spronken, M.I., Fraaij, P.L., et al. Transmission Routes of Respiratory Viruses among Humans. Curr Opin Virol,
2018, 28: 142–151. DOI:10.1016/j.coiro.2018.01.006.
21. Yan, Y.; Chang, L.; Wang, L. Laboratory Testing of SARS-CoV, MERS-CoV and SARS-CoV-2 (2019-nCoV): Current Status,
Challenges and Countermeasures. Rev Med Virol, 2020, 30: e2106. DOI: 10.1002/rmv.2106.
22. CDC. Human Coronavirus Types. Centers for Disease Control and Prevention. URL: https://www.cdc.gov/coronavirus/types.html(дата обращения: 13.03.2023).
23. Su, S., Wong, G., Shi, W., Liu, J., Lai, A.C.K., Zhou, J., Liu, W., Bi, Y., Gao, G.F. Epidemiology, Genetic Recombination and
Pathogenesis of Coronaviruses. Trends Microbiol, 2016, 24: 490–502. DOI: 10.1016/j.tim.2016.03.003.
24. Vassilara, F., Spyridaki, A., Pothitos, G., Deliveliotou, A., Papadopoulos, A. A Rare Case of Human Coronavirus 229E Associated with Acute Respiratory Distress Syndrome in a Healthy Adult. Case Rep Infect Dis, 2018: 6796839. DOI: 10.1155/2018/6796839.
25. Sun, W., Liao, J.-P., Yu, K.-Y., Qiu, J.-X., Que, C.-L., Wang, G.-F., Ma, J. A Severe Case of Human Coronavirus 229E Pneumonia in an Elderly Man with Diabetes Mellitus: A Case Report. BMC Infect Dis, 2021, 21: 524. DOI: 10.1186/s12879-021-06270-1.
26. Van der Hoek, L., Pyrc, K., Jebbink, M.F., Vermeulen-Oost, W., Berkhout, R.J.M., et al. Identification of a New Human Coronavirus. Nat Med, 2004, 10: 368–373. DOI: 10.1038/nm1024.
27. Huynh, J., Li, S., Yount, B., Smith, A., Sturges, L., Olsen, J.C., et al. Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63. J Virol, 2012, 86: 12816–12825. DOI: 10.1128/JVI.00906-12.
28. Woo, P.C.Y., Lau, S.K.P., Chu, C., Chan, K., Tsoi, H., Huang, Y., Wong, B.H.L., et al. Characterization and Complete Genome Se
quence of a Novel Coronavirus, Coronavirus HKU1. J Virol, 2005, 79: 884–895. DOI: 10.1128/JVI.79.2.884-895.2005.
29. Fung, T.S., Liu, D.X. Human Coronavirus: Host-Pathogen Interaction. Annu Rev Microbiol, 2019, 73: 529–557. DOI: 10.1146/annurev-micro-020518-115759.
30. Abdul-Rasool, S., Fielding, B.C. Understanding Human Coronavirus HCoV-NL63. Open Virol J, 2010, 4: 76–84. DOI:
10.2174/1874357901004020076.
31. Kutter, J.S., Spronken, M.I., Fraaij, P.L., Fouchier, R.A., Herfst, S. Transmission Routes of Respiratory Viruses among Humans.
Curr Opin Virol, 2018, 28: 142–151. DOI: 10.1016/j.coviro.2018.01.006.
32. Liu, D.X., Liang, J.Q., Fung, T.S. Human Coronavirus-229E, -OC43, -NL63 and -HKU1 (Coronaviridae). In Encyclopedia of Vi
rology; Elsevier: Amsterdam, The Netherlands, 2021; pp. 428–440. DOI: 10.1016/B978-0-12-814515-9.00078-8.
33. Yip, A.J.W., Low, Z.Y., Chow, V.T.K., Lal, S.K. Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity.Viruses, 2022, 14: 1345. DOI: 10.3390/v14071345.
Для цитирования

Бейшембаев М.И., Азизова М.А., Балпаев У.Д., Курбанова К.А. Пандемия коронавируса COVID-19 и рак легкого (обзор литературы). Научно-практический журнал «Здравоохранение Кыргызстана» 2024, № 4, с.157-163.  https://dx.doi.org/10.51350/zdravkg2024.4.12.20.157.163
English
About authors

Beyshembaev Mukash Itikulovich, Doctor of Medical Sciences, Professor, Leading Researcher, National Center for Oncology and Hematology, Department of Thoracic Oncology  No. 5, Bishkek, Kyrgyz Republic

Azizova Meerim Azizovna, oncologist, National Center of Oncology and Hematology, Department of Thoracic Oncology No. 5, Bishkek, Kyrgyz Republic
Balpaev Uran Dokturbekovich, oncologist, National Center of Oncology and Hematology, Department of Thoracic Oncology No. 5, Bishkek, Kyrgyz Republic

Kurbanova Kamilla Abdymazhitovna, oncologist, National Center of Oncology and Hematology, Department of Thoracic Oncology No. 5, Bishkek, Kyrgyz Republic

 
References

1. Association of Oncologists of Russia. Results of the round table on lung cancer treatment. – 2021. – URL: https://oncology-as<br< a=""> />sociation.ru/itogi-kruglogo-stola-v-oblasti-lecheniya-raka-legkogo
2. Zhu, N., Zhang, D., Wang, W., et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 2020,
382(8): 727–733. DOI: 10.1056/NEJMoa2001017.
3. Worldometer. COVID-19 Coronavirus Pandemic. 2023. URL: </br<>https://www.worldometers.info/coronavirus/ (date of access:
25.03.2023).
4. Hu, B., Guo, H., Zhou, P., Shi, Z.-L. Characteristics of SARS-CoV-2 and COVID-19. NatRev Microbiol, 2021, 19(3): 141–154.
DOI: 10.1038/s41579-020-00459-7.
5. Liang, W., Guan, W., Chen, R., Wang, W., et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet
Oncol, 2020, 21(3): 335–337. DOI:10.1016/S1470-2045(20)30096-6.
6. Liu, S. T. H., Lin, H.-M., Baine, I., et al. Convalescent Plasma Treatment of Severe COVID-19. Nat Med 2020, 26:1708–1713.
DOI: 10.1038/s41591-020-1088-9.
7. Low, Z.Y., Yip, A.J.W., Lal, S.K. Repositioning Ivermectin for COVID-19 Treatment: Molecular Mechanisms of Action against
SARS-CoV-2 Replication. Biochim Biophys Acta Mol Basis Dis, 2022, 1868: 166294. DOI: 10.1016/j.bbadis.2020.166294.
8. Jo, W.K., Drosten, C., Drexler, J.F. The Evolutionary Dynamics of Endemic Human Coronaviruses. Virus Evol, 2021, 7: veab020.
DOI: 10.1093/ve/veab020.
9. Xu, Y., Liu, H., Hu, K., Wang, M. Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coro
navirus Disease (COVID-19). Zhongguo Fei Ai Za Zhi, 2020, 23(3): 136–141. DOI: 10.3779/j.issn.1009-3419.2020.
10. Huynh, J., Li, S., Yount, B., et al. Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63. J Virol, 2012, 86:
12816–12825. DOI: 10.1128/JVI.00906-12.
11. Woo, P. C. Y., Lau, S. K. P., Chu, C., et al. Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1. J Virol 2005, 79:884–895. DOI: 10.1128/JVI.79.2.884-895.2005.
12. Fung, T.S., Liu, D.X. Human Coronavirus: Host-Pathogen Interaction. Annu Rev Microbiol, 2019, 73:529–557. DOI: 10.1146/annurev-micro-020518-115759.

13. Abdul-Rasool, S., Fielding, B.C. Understanding Human Coronavirus HCoV-NL63.Open Virol J, 2010, 4: 76–84. DOI:
10.2174/1874357901004020076.
14. Liu, D.X., Liang, J.Q., Fung, T.S. Human Coronavirus-229E, -OC43, -NL63 and -HKU1(Coronaviridae). In Encyclopedia of Vi
rology; Elsevier: Amsterdam, The Netherlands,2021; pp. 428–440. DOI: 10.1016/B978-0-12-814515-9.00078-8.
15. Yip, A.J.W., Low, Z.Y., Chow, V.T.K., Lal, S.K. Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity.Viruses, 2022, 14: 1345. DOI: 10.3390/v14071345.
16. Van der Hoek, L., Pyrc, K., Jebbink, M.F., et al. Identification of a New Human Coronavirus. Nat Med, 2004, 10: 368–373. DOI:
10.1038/nm1024.
17. Sun, W., Liao, J.-P., Yu, K.-Y., et al. A Severe Case of Human Coronavirus 229E Pneumonia in an Elderly Man with Diabetes
Mellitus: A Case Report. BMC Infect Dis, 2021, 21: 524. DOI: 10.1186/s12879-021-06270-1.
18. Lau, S.K.P., Woo, P.C.Y., Li, K.S.M., et al. Discovery of a Novel Coronavirus, China Rattus Coronavirus HKU24, from Norway
Rats. J Virol, 2015, 89: 3076–3092. DOI:10.1128/JVI.03478-14.
19. Zeng, Z.-Q., Chen, D.-H., Tan, W.-P., et al. Epidemiology and Clinical Characteristics of Human Coronaviruses. Eur J Clin Mi
crobiol Infect Dis, 2018, 37: 363–369. DOI: 10.1007/s10096-018-3181-1.
20. Kutter, J.S., Spronken, M.I., Fraaij, P.L., et al. Transmission Routes of Respiratory Viruses among Humans. Curr Opin Virol,
2018, 28: 142–151. DOI:10.1016/j.coiro.2018.01.006.
21. Yan, Y.; Chang, L.; Wang, L. Laboratory Testing of SARS-CoV, MERS-CoV and SARS-CoV-2 (2019-nCoV): Current Status,
Challenges and Countermeasures. Rev Med Virol, 2020, 30: e2106. DOI: 10.1002/rmv.2106.
22. CDC. Human Coronavirus Types. Centers for Disease Control and Prevention. URL: https://www.cdc.gov/coronavirus/types.html(дата обращения: 13.03.2023).
23. Su, S., Wong, G., Shi, W., Liu, J., Lai, A.C.K., Zhou, J., Liu, W., Bi, Y., Gao, G.F. Epidemiology, Genetic Recombination and
Pathogenesis of Coronaviruses. Trends Microbiol, 2016, 24: 490–502. DOI: 10.1016/j.tim.2016.03.003.
24. Vassilara, F., Spyridaki, A., Pothitos, G., Deliveliotou, A., Papadopoulos, A. A Rare Case of Human Coronavirus 229E Associated with Acute Respiratory Distress Syndrome in a Healthy Adult. Case Rep Infect Dis, 2018: 6796839. DOI: 10.1155/2018/6796839.
25. Sun, W., Liao, J.-P., Yu, K.-Y., Qiu, J.-X., Que, C.-L., Wang, G.-F., Ma, J. A Severe Case of Human Coronavirus 229E Pneumonia in an Elderly Man with Diabetes Mellitus: A Case Report. BMC Infect Dis, 2021, 21: 524. DOI: 10.1186/s12879-021-06270-1.
26. Van der Hoek, L., Pyrc, K., Jebbink, M.F., Vermeulen-Oost, W., Berkhout, R.J.M., et al. Identification of a New Human Coronavirus. Nat Med, 2004, 10: 368–373. DOI: 10.1038/nm1024.
27. Huynh, J., Li, S., Yount, B., Smith, A., Sturges, L., Olsen, J.C., et al. Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63. J Virol, 2012, 86: 12816–12825. DOI: 10.1128/JVI.00906-12.
28. Woo, P.C.Y., Lau, S.K.P., Chu, C., Chan, K., Tsoi, H., Huang, Y., Wong, B.H.L., et al. Characterization and Complete Genome Se
quence of a Novel Coronavirus, Coronavirus HKU1. J Virol, 2005, 79: 884–895. DOI: 10.1128/JVI.79.2.884-895.2005.
29. Fung, T.S., Liu, D.X. Human Coronavirus: Host-Pathogen Interaction. Annu Rev Microbiol, 2019, 73: 529–557. DOI: 10.1146/annurev-micro-020518-115759.
30. Abdul-Rasool, S., Fielding, B.C. Understanding Human Coronavirus HCoV-NL63. Open Virol J, 2010, 4: 76–84. DOI:
10.2174/1874357901004020076.
31. Kutter, J.S., Spronken, M.I., Fraaij, P.L., Fouchier, R.A., Herfst, S. Transmission Routes of Respiratory Viruses among Humans.
Curr Opin Virol, 2018, 28: 142–151. DOI: 10.1016/j.coviro.2018.01.006.
32. Liu, D.X., Liang, J.Q., Fung, T.S. Human Coronavirus-229E, -OC43, -NL63 and -HKU1 (Coronaviridae). In Encyclopedia of Vi
rology; Elsevier: Amsterdam, The Netherlands, 2021; pp. 428–440. DOI: 10.1016/B978-0-12-814515-9.00078-8.
33. Yip, A.J.W., Low, Z.Y., Chow, V.T.K., Lal, S.K. Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity.Viruses, 2022, 14: 1345. DOI: 10.3390/v14071345.
For citation

Beyshembayev M.I., Azizova M.A., Balpaev U.D., Kurbanova K.A.COVID-19 Pandemic and Lung Cancer (Literature
Review).Scientific and practical journal “Health care of Kyrgyzstan” 2024, No.4, p.157-163. https://dx.doi.org/10.51350/zdravkg2024.4.12.20.157.163
Kyrgyz
Авторлор жөнүндө

Бейшембаев Мукаш Итикулович, медицина илимдеринин доктору, профессор, Улуттук онкология жана гематология борборунун жетектөөчү илимий кызматкери, №5 көкүрөк онкологиясы кафедрасы, Бишкек, Кыргыз Республикасы
Азизова Мээрим Азизовна, Улуттук онкология жана гематология борборунун №5 көкүрөк онкология бөлүмүнүн онкологу, Бишкек, Кыргыз Республикасы
Балпаев Уран Доктурбекович, Улуттук онкология жана гематология борборунун №5 көкүрөк онкология бөлүмүнүн онкологу, Бишкек, Кыргыз Республикасы
Курбанова Камилла Абдымажитовна, Улуттук онкология жана гематология борборунун №5 көкүрөк онкология бөлүмүнүн онкологу, Бишкек, Кыргыз Республикасы
Шилтемелер

1. Россиянын онкологдорунун ассоциациясы. Өпкө рагын дарылоо жаатындагы тегерек столдун жыйынтыгы. – 2021. – URL: https://oncology-as<br< a=""> />sociation.ru/itogi-kruglogo-stola-v-oblasti-lecheniya-raka-legkogo
2. Чжу, Н., Чжан, Д., Ванг, В., ж.б. Кытайдагы пневмония менен ооруган жаңы коронавирус, 2019. N Engl J Med, 2020,
382(8): 727–733. DOI: 10.1056/NEJMoa2001017.
3. Worldometer. COVID-19 Коронавирустук пандемия. 2023. URL: </br<>https://www.worldometers.info/coronavirus/ (кирүү күнү:25.03.2023).
4. Ху, Б., Го, Х., Чжоу, П., Ши, З.-Л. SARS-CoV-2 жана COVID-19 мүнөздөмөлөрү. NatRev Microbiol, 2021, 19(3): 141–154.
DOI: 10.1038/s41579-020-00459-7.
5. Liang, W., Guan, W., Chen, R., Wang, W., et al. SARS-CoV-2 инфекциясындагы онкологиялык оорулуулар: Кытайдагы жалпы улуттук анализ. Лансет Онкол, 2020, 21(3): 335–337. DOI:10.1016/S1470-2045(20)30096-6.
6. Liu, S.T.H., Lin, H.-M., Baine, I., et al. Оор COVID-19 үчүн конвалесценттик плазма менен дарылоо. Нат Мед, 2020, 26: 1708–1713. DOI: 10.1038/s41591-020-1088-9.
7. Low, Z.Y., Yip, A.J.W., Lal, S.K. Ивермектинди COVID-19 дарылоо үчүн кайра жайгаштыруу: каршы аракеттенүүнүн молекулярдык механизмдери SARS-CoV-2 репликациясы. Biochim Biophys Acta Mol Basis Dis, 2022, 1868: 166294. DOI: 10.1016/j.bbadis.2020.166294.
8. Джо, В.К., Дростен, Ч., Дрекслер, Дж.Ф. Адамдын эндемикалык коронавирустарынын эволюциялык динамикасы. Virus Evol, 2021, 7: veab020. DOI: 10.1093/ve/veab020.
9. Xu, Y., Liu, H., Hu, K., Wang, M. 2019 Роман Коро башталганда өпкө рагы менен ооруган бейтаптарды клиникалык башкаруунавирус оорусу (COVID-19). Чжунго Фэй Ай За Чжи, 2020, 23(3): 136–141. DOI: 10.3779/j.issn.1009-3419.2020.
10. Huynh, J., Li, S., Yount, B., et al. Адамдын NL63 коронавирусунун штаммынын зооноздук келип чыгышын колдогон далилдер. Дж Вирол, 2012, 86:12816–12825. DOI: 10.1128/JVI.00906-12.
11. Woo, P.C.Y., Lau, S.K.P., Chu, C., et al. Жаңы коронавирустун, Коронавирустун мүнөздөмөсү жана толук геномунун ырааттуулугу HKU1. Дж Вирол, 2005, 79: 884–895. DOI: 10.1128/JVI.79.2.884-895.2005.
12. Фунг, Т.С., Лю, Д.Х. Адамдын коронавирусу: Хост-патогендин өз ара аракеттенүүсү. Annu Rev Microbiol, 2019, 73: 529–557. DOI: 10.1146/annurev-micro-020518-115759.

13. Abdul-Rasool, S., Fielding, B.C. Understanding Human Coronavirus HCoV-NL63.Open Virol J, 2010, 4: 76–84. DOI:
10.2174/1874357901004020076.
14. Liu, D.X., Liang, J.Q., Fung, T.S. Human Coronavirus-229E, -OC43, -NL63 and -HKU1(Coronaviridae). In Encyclopedia of Vi
rology; Elsevier: Amsterdam, The Netherlands,2021; pp. 428–440. DOI: 10.1016/B978-0-12-814515-9.00078-8.
15. Yip, A.J.W., Low, Z.Y., Chow, V.T.K., Lal, S.K. Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity.Viruses, 2022, 14: 1345. DOI: 10.3390/v14071345.
16. Van der Hoek, L., Pyrc, K., Jebbink, M.F., et al. Identification of a New Human Coronavirus. Nat Med, 2004, 10: 368–373. DOI:
10.1038/nm1024.
17. Sun, W., Liao, J.-P., Yu, K.-Y., et al. A Severe Case of Human Coronavirus 229E Pneumonia in an Elderly Man with Diabetes
Mellitus: A Case Report. BMC Infect Dis, 2021, 21: 524. DOI: 10.1186/s12879-021-06270-1.
18. Lau, S.K.P., Woo, P.C.Y., Li, K.S.M., et al. Discovery of a Novel Coronavirus, China Rattus Coronavirus HKU24, from Norway
Rats. J Virol, 2015, 89: 3076–3092. DOI:10.1128/JVI.03478-14.
19. Zeng, Z.-Q., Chen, D.-H., Tan, W.-P., et al. Epidemiology and Clinical Characteristics of Human Coronaviruses. Eur J Clin Mi
crobiol Infect Dis, 2018, 37: 363–369. DOI: 10.1007/s10096-018-3181-1.
20. Kutter, J.S., Spronken, M.I., Fraaij, P.L., et al. Transmission Routes of Respiratory Viruses among Humans. Curr Opin Virol,
2018, 28: 142–151. DOI:10.1016/j.coiro.2018.01.006.
21. Yan, Y.; Chang, L.; Wang, L. Laboratory Testing of SARS-CoV, MERS-CoV and SARS-CoV-2 (2019-nCoV): Current Status,
Challenges and Countermeasures. Rev Med Virol, 2020, 30: e2106. DOI: 10.1002/rmv.2106.
22. CDC. Human Coronavirus Types. Centers for Disease Control and Prevention. URL: https://www.cdc.gov/coronavirus/types.html(дата обращения: 13.03.2023).
23. Su, S., Wong, G., Shi, W., Liu, J., Lai, A.C.K., Zhou, J., Liu, W., Bi, Y., Gao, G.F. Epidemiology, Genetic Recombination and
Pathogenesis of Coronaviruses. Trends Microbiol, 2016, 24: 490–502. DOI: 10.1016/j.tim.2016.03.003.
24. Vassilara, F., Spyridaki, A., Pothitos, G., Deliveliotou, A., Papadopoulos, A. A Rare Case of Human Coronavirus 229E Associated with Acute Respiratory Distress Syndrome in a Healthy Adult. Case Rep Infect Dis, 2018: 6796839. DOI: 10.1155/2018/6796839.
25. Sun, W., Liao, J.-P., Yu, K.-Y., Qiu, J.-X., Que, C.-L., Wang, G.-F., Ma, J. A Severe Case of Human Coronavirus 229E Pneumonia in an Elderly Man with Diabetes Mellitus: A Case Report. BMC Infect Dis, 2021, 21: 524. DOI: 10.1186/s12879-021-06270-1.
26. Van der Hoek, L., Pyrc, K., Jebbink, M.F., Vermeulen-Oost, W., Berkhout, R.J.M., et al. Identification of a New Human Coronavirus. Nat Med, 2004, 10: 368–373. DOI: 10.1038/nm1024.
27. Huynh, J., Li, S., Yount, B., Smith, A., Sturges, L., Olsen, J.C., et al. Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63. J Virol, 2012, 86: 12816–12825. DOI: 10.1128/JVI.00906-12.
28. Woo, P.C.Y., Lau, S.K.P., Chu, C., Chan, K., Tsoi, H., Huang, Y., Wong, B.H.L., et al. Characterization and Complete Genome Se
quence of a Novel Coronavirus, Coronavirus HKU1. J Virol, 2005, 79: 884–895. DOI: 10.1128/JVI.79.2.884-895.2005.
29. Fung, T.S., Liu, D.X. Human Coronavirus: Host-Pathogen Interaction. Annu Rev Microbiol, 2019, 73: 529–557. DOI: 10.1146/annurev-micro-020518-115759.
30. Abdul-Rasool, S., Fielding, B.C. Understanding Human Coronavirus HCoV-NL63. Open Virol J, 2010, 4: 76–84. DOI:
10.2174/1874357901004020076.
31. Kutter, J.S., Spronken, M.I., Fraaij, P.L., Fouchier, R.A., Herfst, S. Transmission Routes of Respiratory Viruses among Humans.
Curr Opin Virol, 2018, 28: 142–151. DOI: 10.1016/j.coviro.2018.01.006.
32. Liu, D.X., Liang, J.Q., Fung, T.S. Human Coronavirus-229E, -OC43, -NL63 and -HKU1 (Coronaviridae). In Encyclopedia of Vi
rology; Elsevier: Amsterdam, The Netherlands, 2021; pp. 428–440. DOI: 10.1016/B978-0-12-814515-9.00078-8.
33. Yip, A.J.W., Low, Z.Y., Chow, V.T.K., Lal, S.K. Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity.Viruses, 2022, 14: 1345. DOI: 10.3390/v14071345.
Цитата үчүн

Бейшембаев М.И., Азизова М.А., Балпаев У.Д., Курбанова К.А. COVID-19 Пандемиясы жана опкөнун залалдуу шишиктери (Адабиятка Сын көз караш). "Кыргызстандын саламаттык сактоо" илимий-практикалык журналы
2024, № 4, б. 157-163.  https://dx.doi.org/10.51350/zdravkg2024.4.12.20.157.163
Views: 24
Copyright MAXXmarketing GmbH
JoomShopping Download & Support